InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-7.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Marsh Linda, Director. Director active across 3 companies, notably Fulgent Genetics, Inc.. In total, 13 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €8.8m. History available since 20 May 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
8,982 shares0Common StockSEC:0000950170-25-074718:0
11,000 shares@ US$15.35100.0% of flowCommon StockSEC:0001104659-24-099376:0
3,564 shares0Common StockSEC:0001104659-24-089699:0
8,000 shares0Common StockSEC:0000950170-24-062569:0
3,650 shares0Common StockSEC:0001104659-23-126904:0
5,059 shares0Common StockSEC:0001209191-23-031477:0
270,081 shares@ US$35.3248.7% of flowCommon StockSEC:0001628280-23-008109:0
62,500 shares@ US$10.003.2% of flowCommon StockSEC:0001250853-23-000009:0
1,600 shares0Common StockSEC:0001209191-22-044294:0
250,000 shares@ US$37.00100.0% of flowCommon StockSEC:0001104659-22-072514:0
2,000 shares0Common StockSEC:0001209191-22-030961:0
2,000 shares0Common StockSEC:0001209191-21-035452
2,000 shares0Common StockSEC:0001209191-21-035452:0
13 of 13 declarations
About Marsh Linda
Linda Marsh is a Board Member at Fulgent Genetics, Inc. and Apollo Medical Holdings, Inc. She brings expertise in management and strategy, contributing to decision-making within the boards. Her role includes overseeing operations and developing policies to ensure compliance and ethics within the organizations.
